All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0430 | Human anti-glia-α T cell receptor ((380)-1), pCDTCR1 | Triticum aestivum | 380 | Human | PFPQPQLPY + DEAM(Q6) | HLA-DQ2 | Lentiviral vector | |
TCR-YC0431 | Human anti-glia-α T cell receptor ((380)-2), pCDTCR1 | Triticum aestivum | 380 | Human | PQPQLPYPQ + DEAM(Q4) | HLA-DQ2 | Lentiviral vector | |
TCR-YC0432 | Human anti-glia-α T cell receptor (578.14), pCDTCR1 | Triticum aestivum | 578.14 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0433 | Human anti-glia-α T cell receptor (578.2), pCDTCR1 | Triticum aestivum | 578.2 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0434 | Human anti-glia-α T cell receptor (578.3), pCDTCR1 | Triticum aestivum | 578.3 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0435 | Human anti-glia-α T cell receptor (578.4), pCDTCR1 | Triticum aestivum | 578.4 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0436 | Human anti-glia-α T cell receptor (578.75), pCDTCR1 | Triticum aestivum | 578.75 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0437 | Human anti-glia-α T cell receptor (737.51), pCDTCR1 | Triticum aestivum | 737.51 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0438 | Human anti-glia-α T cell receptor (737.58), pCDTCR1 | Triticum aestivum | 737.58 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0439 | Human anti-glia-α T cell receptor (737.6), pCDTCR1 | Triticum aestivum | 737.6 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0440 | Human anti-glia-α T cell receptor (737.68), pCDTCR1 | Triticum aestivum | 737.68 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0441 | Human anti-glia-α T cell receptor (737.78), pCDTCR1 | Triticum aestivum | 737.78 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0442 | Human anti-glia-α T cell receptor (Clone 10), pCDTCR1 | Triticum aestivum | clone 10 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0443 | Human anti-glia-α T cell receptor (Clone 5), pCDTCR1 | Triticum aestivum | clone 5 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0444 | Human anti-glia-α T cell receptor (Clone 6), pCDTCR1 | Triticum aestivum | clone 6 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0445 | Human anti-glia-α T cell receptor (Clone 7), pCDTCR1 | Triticum aestivum | clone 7 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0446 | Human anti-glia-α T cell receptor (Clone 8), pCDTCR1 | Triticum aestivum | clone 8 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0447 | Human anti-glia-α T cell receptor (Clone 9), pCDTCR1 | Triticum aestivum | clone 9 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC0448 | Human anti-glia-α T cell receptor (SP3.4), pCDTCR1 | Triticum aestivum | SP3.4 | Human | QQYPSGQGSFQPSQQNPQ + DEAM(Q7, Q15) | HLA-DQA1*03:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC0449 | Human anti-glia-α T cell receptor (TCC737.A4B30), pCDTCR1 | Triticum aestivum | TCC737.A4B30 | Human | PQPQLPYPQPQ + DEAM(Q4, Q11) | HLA-DQ2.5 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION